-
EP0882067
European procedure
Extract from the Register of European Patents
EP About this file: EP0882067
| EP0882067 - METHODS OF TREATING VASCULAR DISEASE WITH TNF ANTAGONISTS [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 20.03.2009 Database last updated on 24.08.2024 | Most recent event Tooltip | 01.01.2010 | Lapse of the patent in a contracting state New state(s): AT, LU | published on 03.02.2010 [2010/05] | Applicant(s) | For all designated states THE MATHILDA AND TERRENCE KENNEDY INSTITUTE OF RHEUMATOLOGY TRUST 1 Aspenlea Road Hammersmith, London W6 8LH / GB | [N/P] |
| Former [2009/17] | For all designated states THE KENNEDY INSTITUTE OF RHEUMATOLOGY 1 Aspenlea Road Hammersmith, London W6 8LH / GB | ||
| Former [1998/50] | For all designated states THE KENNEDY INSTITUTE OF RHEUMATOLOGY 1 Aspenlea Road Hammersmith, London W6 8LH / GB | Inventor(s) | 01 /
ELLIOTT, Michael James Herdman 12 Hart Grove, Ealing London W5 3NB / GB | 02 /
MAINI, Ravinda Nath 151 Castelnau, Barnes London SW13 9EW / GB | 03 /
FELDMANN, Marc 2 Church Road Highgate, London N6 4QT / GB | [1998/50] | Representative(s) | Kirkham, Nicholas Andrew, et al Graham Watt & Co. LLP St. Botolph's House 7-9 St. Botolph's Road Sevenoaks, Kent TN13 3AJ / GB | [N/P] |
| Former [1998/50] | Kirkham, Nicholas Andrew, et al Graham Watt & Co., Riverhead Sevenoaks, Kent TN13 2BN / GB | Application number, filing date | 97903485.7 | 17.02.1997 | [1998/50] | WO1997GB00435 | Priority number, date | US19960602272 | 16.02.1996 Original published format: US 602272 | [1998/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9730088 | Date: | 21.08.1997 | Language: | EN | [1997/36] | Type: | A2 Application without search report | No.: | EP0882067 | Date: | 09.12.1998 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.08.1997 takes the place of the publication of the European patent application. | [1998/50] | Type: | B1 Patent specification | No.: | EP0882067 | Date: | 12.11.2003 | Language: | EN | [2003/46] | Type: | B2 New European patent specification | No.: | EP0882067 | Date: | 22.04.2009 | Language: | EN | [2009/17] | Search report(s) | International search report - published on: | EP | 09.10.1997 | Classification | IPC: | C07K16/24, A61K39/395, A61K31/00 | [1998/50] | CPC: |
C07K16/248 (EP,US);
A61K31/00 (EP,US);
A61K31/4015 (EP,US);
A61K31/404 (EP,US);
A61K31/454 (EP,US);
A61K31/522 (EP,US);
A61P7/00 (EP);
A61P7/02 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
C07K14/7151 (EP,US);
C07K16/241 (EP,US);
A61K2039/505 (EP,US);
A61K38/00 (EP,US);
C07K2317/24 (EP,US);
C07K2317/34 (EP,US);
C07K2317/52 (EP,US);
C07K2319/30 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1998/50] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON GEFÄSSKRANKHEITEN MITTELS TUMORNEKROSEFAKTOR-ANTAGONISTEN | [1998/50] | English: | METHODS OF TREATING VASCULAR DISEASE WITH TNF ANTAGONISTS | [1998/50] | French: | PROCEDES DE TRAITEMENT D'UNE MALADIE VASCULAIRE AU MOYEN D'ANTAGONISTES DU TNF (FACTEUR DE NECROSE TUMORALE) | [1998/50] | Entry into regional phase | 10.09.1998 | National basic fee paid | 10.09.1998 | Designation fee(s) paid | 10.09.1998 | Examination fee paid | Examination procedure | 25.08.1997 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 10.09.1998 | Examination requested [1998/50] | 31.08.2001 | Despatch of a communication from the examining division (Time limit: M06) | 11.03.2002 | Reply to a communication from the examining division | 19.03.2003 | Communication of intention to grant the patent | 11.09.2003 | Fee for grant paid | 11.09.2003 | Fee for publishing/printing paid | Divisional application(s) | EP03025867.7 / EP1460087 | EP06013226.3 Application deemed to be withdrawn : 28.07.2006 | Opposition(s) | Opponent(s) | 01
12.08.2004
02.12.2004
WITHDRAWN Serono International S.A. 15bis Chemin des Mines 1202 GENEVA / CH Opponent's representative Vogelsang-Wenke, Heike Grünecker Kinkeldey Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE | [N/P] |
| Former [2005/04] | |||
| Opponent(s) | 01
12.08.2004
02.12.2004
WITHDRAWN SERONO INTERNATIONAL S.A. 15bis Chemin des Mines 1202 GENEVA / CH Opponent's representative Vogelsang-Wenke, Heike, Dr. Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | ||
| Former [2004/41] | |||
| Opponent(s) | 01
12.08.2004
WITHDRAWN SERONO INTERNATIONAL S.A. 15bis Chemin des Mines 1202 GENEVA / CH Opponent's representative Vogelsang-Wenke, Heike, Dr. Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | 20.09.2004 | Invitation to proprietor to file observations on the notice of opposition | 27.05.2005 | Reply of patent proprietor to notice(s) of opposition | 10.02.2006 | Despatch of a communication from the opposition division (Time limit: M08) | 20.10.2006 | Reply to a communication from the opposition division | 28.02.2008 | Cancellation of oral proceeding that was planned for 03.03.2008 | 28.02.2008 | Despatch of minutes of oral proceedings | 03.03.2008 | Date of oral proceedings | 23.06.2008 | Despatch of interlocutory decision in opposition | 03.07.2008 | Legal effect of interlocutory decision in opposition | 05.12.2008 | Despatch of communication that the patent will be maintained as amended | 12.03.2009 | Fee for printing new specification paid | Fees paid | Renewal fee | 19.02.1999 | Renewal fee patent year 03 | 17.02.2000 | Renewal fee patent year 04 | 20.02.2001 | Renewal fee patent year 05 | 21.01.2002 | Renewal fee patent year 06 | 20.01.2003 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 12.11.2003 | LU | 17.02.2007 | MC | 28.02.2007 | [2010/05] |
| Former [2008/07] | MC | 28.02.2007 | Cited in | International search | [X]EP0260610 (BASF AG [DE]) [X] 1-9,51-53 * claims 1-11 * * page 3, line 37 - line 43 *; | [X]WO9115451 (SMITHKLINE BEECHAM PHARMA GMBH [DE], et al) [X] 1-7,51-53 * claims 1-21 *; | [X]EP0453898 (BAYER AG [DE]) [X] 1-9,51-53 * the whole document *; | [XY]EP0486809 (ERBA CARLO SPA [IT]) [X] 1-7,28,51-53 * claims 1-6 * * page 4, column 6, line 17 - page 5, column 7, line 46 * [Y] 16-22,24-27; | [YD]WO9216553 (UNIV NEW YORK [US], et al) [YD] 10,11,13-15 * claims 1-42 *; | [X]WO9410990 (BRITISH BIO TECHNOLOGY [GB], et al) [X] 1-7,23,51-53 * claims 1-21 *; | [XY]EP0626389 (CELLTECH LTD [GB]) [X] 1-9,12,51-53 * claims 1-8 * * page 10, line 18 - line 37 * [Y] 10,11,13-15; | [X]WO9519957 (BRITISH BIOTECH PHARM [GB], et al) [X] 1-7,51-53 * claims 1-11 *; | [YD]US5447851 (BEUTLER BRUCE A [US], et al) [YD] 16-22 * column 1, line 14 - line 45 * * column 9, line 7 - line 24 *; | [AD]GB2289218 (MERCK & CO INC [US]) [AD] 1-53 * claims 1-7 *; | [XP]WO9621447 (OTSUKA PHARMA CO LTD [JP], et al) [XP] 1-7,23,51-53 * claims 1-8 *; | [Y] - DAVIDSEN S K ET AL, "INHIBITORS OF TNF ASPIRE SYNTHESIS PULMONARY-ALLERGY, DERMATOLOGICAL, GASTROINTESTINAL & ARTHRITIS", EXPERT OPINION ON THERAPEUTIC PATENTS, (19950101), vol. 5, no. 10, pages 1087 - 1100, XP000575712 [Y] 24-27 * the whole document * DOI: http://dx.doi.org/10.1517/13543776.5.10.1087 | [A] - NEUNER P ET AL, "PENTOXIFYLLINE IN VIVO DOWN-REGULATES THE RELEASE OF IL-1 BETA,IL-6, IL-8 AND TUMOUR NECROSIS FACTOR-ALPHA BY HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS", IMMUNOLOGY, (19941001), vol. 83, no. 2, pages 262 - 267, XP000560400 [A] 1-53 * the whole document * | [A] - JOHN C. LEE ET AL, "Low-Molecular-Weight TNF Biosynthesis inhibitors: Strategies and Prospectives", CIRCULATORY SHOCK, (199411), vol. 44, pages 97 - 103, XP000575652 [A] 1-53 * the whole document * |